Trexquant Investment LP

Position in TGTX — Tg Therapeutics, Inc.

CIK 1633445 STAMFORD, CT

Position in TGTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,338,695

-$4,937,558 QoQ

Shares Held

311,219

-39.3% QoQ

Ownership

0.203%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $496,284,956 across 119 Biotechnology names. TGTX ranks #9 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,338,695	311,219	-39.3%	Shares	Sole	2026-05-15
2025-12-31	$15,276,253	512,454	+92.4%	Shares	Sole	2026-02-17
2025-09-30	$9,623,591	266,397	+702.5%	Shares	Sole	2025-11-14
2025-06-30	$1,194,688	33,195	-58.7%	Shares	Sole	2025-08-12
2024-09-30	$1,882,146	80,468	-46.1%	Shares	Sole	2024-11-12
2024-06-30	$2,658,146	149,418	-57.3%	Shares	Sole	2024-08-13
2023-12-31	$5,981,723	350,218	-10.3%	Shares	Sole	2024-02-09
2023-09-30	$3,264,638	390,507	+170.3%	Shares	Sole	2023-11-13
2023-06-30	$3,589,007	144,485	-62.6%	Shares	Sole	2023-08-11
2022-12-31	$4,571,904	386,467	+992.7%	Shares	Sole	2023-02-13
2022-09-30	$209,384	35,369	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.